Navigation Links
MedImmune Presents Data Highlighting its Progressive Oncology Portfolio at Annual Meeting of the American Association For Cancer Research
Date:4/10/2008

er section 28, board 9) - Jon Cheesebrough, Tuesday,

April 15 from 1:00 - 5:00 p.m. in Exhibit Hall B-F.

-- IPI-504, a Selective Hsp90 Inhibitor is Biologically Active and

Tolerated in Combination with Trastuzumab in Preclinical Models of HER2

Positive Tumor Xenografts (Poster Session: Drug Discovery 2:

Combination Strategies I, abstract 4008, poster section 29, board 6)

- Ching Ching Leow, Ph.D., Tuesday, April 15 from 8:00 a.m. - 12:00

p.m. in Exhibit Hall B-F.

-- Bioavailability, Pharmacodynamic Activity, and Anti-Tumor Efficacy of

the CD19/CD3-Specific BiTE Antibody MEDI-538 (MT103) Delivered

Subcutaneously in Animal Models (Poster Session: Antibodies and

Immunotherapy, abstract 2131, poster section 23, board 6) - Kathy

Mulgrew, Monday, April 14 from 8:00 a.m. - 12:00 p.m. in Exhibit Hall

B-F.

-- Inhibition of Growth of Human Lymphoma Xenografts with a

Glycoengineered Antibody Specific for the B-Cell Antigen CD19 (Poster

Session: Antibodies and Immunotherapy, abstract 3980, poster section

28, board 8) - Beth K. Ward, Tuesday, April 15 from 8:00 a.m. - 12:00

p.m. in Exhibit Hall B-F.

-- The Characterization of a Potent, Fully Human MCP-1 Antibody In Vitro

and In Vivo (Poster Session: Antibodies, abstract 3986, poster section

28, board 14) - Z. Alexander Cao, Ph.D., Tuesday, April 15 from 8:00

a.m. - 12:00 p.m. in Exhibit Hall B-F.

About MedImmune

MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on cardiovascular/gastrointestinal disease, neuroscience, oncology, infection, respiratory disease and inflammation. With approximately 3,000 employees worldwide and headquarters in Maryland, Me
'/>"/>

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
2. MedImmune Celebrates Opening of New Pilot Lab at Gaithersburg Headquarters
3. MedImmune Recognized by Local Volunteer Organization for Its Employees Exceptional Commitment to Community Service within Montgomery County
4. MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition
5. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
6. MedImmune Announces Seven Key Promotions and New Hires
7. MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas
8. MedImmune Submits Biologics License Application to FDA for Motavizumab
9. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
10. Seneca Valley High School Student Receives Science Award From MedImmune
11. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008).../ -- SleepQuest is proud to announce,it has earne...ommission on the,Accreditation of Health Care Org...th national standards for health care quality and ...st was evaluated against a set of,national standa...rvey team,",says Debra Zak, Ph.D., RN, L.Ac., exe...
(Date:12/2/2008)... 2 The Patient,Advocate Foundatio...D), is,pleased to announce the launch of the Lymp...ivision, is offering the national, toll-free patie...on and assistance to breast cancer,patients who a...ts such as,lymphedema (swelling due to blockage i...
(Date:12/2/2008)...sociated Cardiovascular Associates,(ACC), a 38-do... locations in,Southern New Jersey, today announce...c health records and Sage Intergy practice managem...e, which cares for more than 30,000 patients,annu...solution to enhance care,delivery, clinical trial...
(Date:12/2/2008)..., Dec. 2 Enigma Diagnostics, the ...ics company, announced today the opening of a new ...f Chris Melancon as Vice President, Business Devel...d on December 1 and is Enigma,s first overseas fac...of rapid diagnostic instrument systems. Enigma,s ...
Breaking Biology Technology:SleepQuest Achieves Coveted Accreditation 2New Program Offers Breast Cancer Clinicians and Patients Support for Pre-Operative Clinical Assessment and Ongoing Surveillance of Lymphedema 2New Program Offers Breast Cancer Clinicians and Patients Support for Pre-Operative Clinical Assessment and Ongoing Surveillance of Lymphedema 3Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 2Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 3Associated Cardiovascular Consultants Selects Sage Intergy EHR to Enhance Quality, Clinical Trial Research and Physician-Patient Relationship 4Enigma Diagnostics Announces the Opening of a United States Office 2Enigma Diagnostics Announces the Opening of a United States Office 3
... Wis. - This summer, venture investors deployed m...s Wisconsin, a total that may bode well for improv...ile it is difficult to draw firm conclusions from ...ld indicate that technologically innovative compan...ase of capital in 2006. , ,"With the growth of the...
... Wis. - The Madison-based National Stem Cell Ban...tem cells from the University of California-San F...available on the federal registry. , ,Beth Donley,...ute , which houses the stem cell bank, said the or...ave all 21 federally approved lines. , ,"We,re ver...
...Wis. - The Center for Advanced Technology and In...ogy-based economic development programs. , ,An awa...uncil recognizes CATI,s work in developing a $40 ...uch as Kraft Foods , S.C. Johnson , and Boeing ...ments, five company product line expansions, and t...
... Wis. - Genetically engineered mice are very expe...ny has developed a method for producing similarly ...io Corp. , a privately-held biopharmaceutical firm...urdles associated with producing modified mice at ... animals instead. , ,Mirus has begun using its spe...
Other Biology Technology:Summer venture investments total $18 million for Wisconsin start ups 2Summer venture investments total $18 million for Wisconsin start ups 3Summer venture investments total $18 million for Wisconsin start ups 4Nation's only stem cell bank will receive UC-San Francisco cell line 2Mirus provides low-cost way to modify genes 2
(Date:12/2/2008)...ywhere else in the world. This is having a major i...nvironment and effect of cities on rural areas. On...ca,s history is being over-looked. , Joy Clancy ...blem in the current issue of the African Journal ...the African population was rural, today 38% live i...
(Date:12/2/2008)...tion due to climate change, pollution and human ac... providing satellite data of the region for the la...ion with ESA,s future missions will be key in impl...icy called ,The European Union and the Arctic Regi...n the region such as the opening up of long-sought...
(Date:12/1/2008)...spread consumption advisories and uncertainty amon...w researchers at North Carolina State University h...d regulators around the country predict which area... a breakthrough that should help officials addres...es for specific water bodies and fish species. , ...
(Date:12/1/2008)...old a colloquium to examine what lies ahead in evo...isms. Leading researchers and students will discus...tion and even evolution from the perspectives of e...ity informatics dealing with microbes, plants, and...he event will take place at the Arnold and Mabel B...
Breaking Biology News(10 mins):ESA satellites focusing on the Arctic 2New model predicts hot spots for mercury in fish 2American Council on Exercise Offers 10 Tips for Surviving the Holidays 2847 1American Council on Exercise Offers 10 Tips for Surviving the Holidays 2847 2IDM Pharma to Present at BIO InvestorForum in San Francisco 1045 1IDM Pharma to Present at BIO InvestorForum in San Francisco 1045 2IDM Pharma to Present at BIO InvestorForum in San Francisco 1045 3Environmental Tectonics Corporations BioMedical Division Announces New Contract 1042 1Environmental Tectonics Corporations BioMedical Division Announces New Contract 1042 2Environmental Tectonics Corporations BioMedical Division Announces New Contract 1042 3Clarient Names Michael J Pellini M D Chief Operating Officer 2845 1Clarient Names Michael J Pellini M D Chief Operating Officer 2845 2Clarient Names Michael J Pellini M D Chief Operating Officer 2845 3Clarient Names Michael J Pellini M D Chief Operating Officer 2845 4
...wly identified gene expression profile could help ...will respond to chemotherapy treatment. Described ...urnal of Clinical Oncology (JCO), the new findings...y gene profiling as a predictor of clinical outcom...clinicians with insights into the mechanisms of dr...
... preliminary results from a study in Botswana, Har...d that people with HIV-1 subtype C in resource-poo...py, can achieve comparable results to those in the...livery system and infrastructure help ensure this ...005 issue of the Journal of Acquired Immune Defici...
...am of researchers led by scientists at Memorial Sl... new class of drugs -- now in early stage clinical... the BRAF gene. BRAF is a protein that plays a cen...ls and is mutated in the majority of patients with..., breast, and lung cancers. The findings, availabl...
...rding to research reported this week in Current Bi...e epicenter of the 2004 Sumatra-Andaman earthquake...mited, particularly when compared to damage from c...0 days after the tsunami of December 26, 2004, a t...Wildlife Conservation Society-Indonesia Program, a...
Other Biology News:Gene expression profile helps predict chemotherapy response in ovarian cancer patients 2Gene expression profile helps predict chemotherapy response in ovarian cancer patients 3New Therapeutic Target Identified In Inherited Brain Tumor Disorder 2Mutations in the BRAF gene predict sensitivity to a novel class of cancer drugs 2
Any form, any size, any number of mutageneses. ExonBio provides the best service with double sequecing to make sure the success of the mutagenesis.
Request Info
Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, glycerol solution.
Epi-Grids™ Colony Grid Templates are easy-to-use griding templates that allow rapid organization of colonies from initial screening plates and for preparing precise master plates.
Biology Products: